Back to Search
SAMANTHA KAPLAN, M.D.
M.D.
Infectious Disease Physician
NPI: 1700310448IndividualAccepts Medicare
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
DR.0070757(CO)
Education
YALE UNIVERSITY SCHOOL OF MEDICINE
Class of 2017
Research & Publications (20)
Implications of recent epidemiology studies for the clinical management of lower urinary tract symptoms.
PMID 19302502·BJU Int·2009
4-observational
Challenges in the evaluation and management of bone and joint infections and the role of new antibiotics for gram positive infections.
PMID 19280853·Adv Exp Med Biol·2009
6-review
PCPT: Evidence that finasteride reduces risk of most frequently detected intermediate- and high-grade (Gleason score 6 and 7) cancer.
PMID 19328538·Urology·2009
2-rct
Commentary: Prevention of recurrent staphylococcal infections.
PMID 18756179·Pediatr Infect Dis J·2008
8-other
Current role of alpha-blockers in the treatment of benign prostatic hyperplasia.
PMID 19032603·BJU Int·2008
6-review
Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial.
PMID 18639298·J Urol·2008
2-rct
Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.
PMID 18405763·J Urol·2008
8-other
Urinary retention and post-void residual urine in men: separating truth from tradition.
PMID 18485378·J Urol·2008
6-review
Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
PMID 18510659·BJU Int·2008
4-observational
Prevalence of an increased ascending thoracic aorta diameter diagnosed by two-dimensional echocardiography versus 64-multislice cardiac computed tomography.
PMID 18157977·Am J Cardiol·2008
4-observational
Introduction: BPH and sexual dysfunction--recommendations for the primary care physician and urologist.
PMID 19002118·Int J Impot Res·2008
8-other
Growth and payment adequacy of medicare postacute care rehabilitation.
PMID 17964895·Arch Phys Med Rehabil·2007
6-review
Open to debate. The motion: PDE5 inhibitors will have a significant role in the treatment of BPH.
PMID 17728048·Eur Urol·2007
6-review
Phosphodiesterase type 5 inhibitors for the treatment of male lower urinary tract symptoms.
PMID 17592540·Rev Urol·2007
8-other
Identification of the patient with enlarged prostate: diagnosis and guidelines for management.
PMID 17620137·Osteopath Med Prim Care·2007
8-other
[The role of muscarinic receptor antagonists in the treatment of men with lower urinary tract symptoms secondary to BPH].
PMID 17645086·Actas Urol Esp·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 12605 E 16TH AVE
AURORA, CO 80045 - Phone
- (720) 848-0000
Quick Facts
- NPI
- 1700310448
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile